Cytarabine CAS 147-94-4

Chemical Name: Cytarabine
Synonyms: 1-beta-d-arabinosylcytosine; beta-arabinosylcytosine; cytarabinoside; Arabinoside C; Cytarabine (Ara-C)
CAS No.: 147-94-4
Molecular Formula: C9H13N3O5
Molecular Weight: 243.22
Appearance:  White crystalline powder

  ... 正在查看此商品

  分享
Guaranteed Safe Checkout

Table of Contents

1. Cytarabine (CAS 147-94-4): Product Overview & Specifications

Chemical Specifications

Parameter Details
CAS Number 147-94-4
Molecular Formula C9H13N3O5
Purity Grade ≥98% (HPLC), Pharmaceutical Grade
Appearance White to off-white crystalline powder
Solubility 50 mg/mL in water (clear, colorless solution)

Comparative Analysis of Commercial Grades

Supplier Purity Packaging Price Range
PharmaCo A 98.5% 1kg/vial $850-$1,200/kg
BioChem Ltd 99.2% 500g/jar $1,100-$1,500/kg
OncoSolutions 99.9% 100mg/ampule $2.50/mg

2. Key Therapeutic Applications & Clinical Use Cases

Primary Medical Indications

  • First-line treatment for acute myeloid leukemia (AML)
  • Component in ALL (Acute Lymphocytic Leukemia) protocols
  • Lymphoma combination therapies

Research Applications

  • DNA synthesis inhibition studies
  • Chemotherapy resistance mechanisms research
  • Combination therapy efficacy trials

3. Pharmacological Mechanism & Biochemical Properties

Mode of Action

  • Competitive inhibition of DNA polymerase
  • Incorporation into DNA strands causing chain termination
  • S-phase specific cytotoxicity

Pharmacokinetic Profile

Parameter Value
Half-life 1-3 hours (IV administration)
Protein Binding 13%
Metabolism Hepatic deamination

4. Clinical Case Studies & Patient Outcomes

Case Study 1: AML Remission Induction

  • Patient: 58yo male with newly diagnosed AML
  • Protocol: 7+3 regimen (100mg/m² continuous infusion)
  • Outcome: Complete remission achieved in 28 days

Case Study 2: Refractory ALL Treatment

  • Patient: 12yo female with relapsed B-cell ALL
  • Protocol: High-dose cytarabine (3g/m² every 12h)
  • Outcome: 90% blast reduction post-cycle 2

5. Administration Protocols & Safety Guidelines

Dosing Recommendations

Regimen Dosage Frequency
Standard AML 100mg/m² Continuous IV (days 1-7)
High-dose 3g/m² 2hr infusion q12h (days 1,3,5)

Adverse Effect Management

  • Myelosuppression monitoring protocol
  • Cerebellar toxicity screening procedures
  • Conjunctivitis prevention strategies

6. Supplier Comparison & Procurement Guidance

Global Supplier Analysis

Vendor Certifications Lead Time MOQ
OncoPharm FDA, EMA, PMDA 4-6 weeks 100g
BioThera WHO-GMP 2-3 weeks 500g

7. Contact for Technical Support & Bulk Orders

For formulation assistance or commercial inquiries:

Email: info@vivalr.com
Tel: (86) 15866781826

Request current COA documentation and stability data sheets.

0.00
0 条评论
5
0
4
0
3
0
2
0
1
0
成为第一个评论 “Cytarabine CAS 147-94-4”

您的邮箱地址不会被公开。 必填项已用 * 标注

这是必填栏。

这是必填栏。

这是必填栏。

评论

目前还没有评论。

类别 
我的购物车
愿望清单
最近浏览
类别
Wait! before you leave…
Get 30% off for your first order
CODE30OFFCopy to clipboard
Use above code to get 30% off for your first order when checkout
比较产品 (0 产品)